Drug intelligence / Profile preview

OraBan

Development stage
Unknown
Lead developer
BASF
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01

Overview

OraBan is a mucoadhesive protective paste developed by Sultan Healthcare for the symptomatic relief of oral mucosal irritations, including aphthous ulcers (canker sores), denture sores, and traumatic lesions. The product is formulated with a combination of gelatin, pectin, and sodium carboxymethylcellulose in a mineral oil and polyethylene base, which allows it to adhere effectively to moist oral tissues. Its primary mechanism of action is the creation of a physical, mechanical barrier that shields sensitive nerve endings from chemical and mechanical triggers such as food, drink, and tongue movement. By providing this protective 'bandage,' OraBan reduces pain and facilitates the natural healing of the oral mucosa without the need for active pharmacological agents like steroids or local anesthetics.

Brand names
OraBan
Other names
OraBan Protective PasteOraban

Beyond the preview

Go deeper on OraBan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OraBan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call